CompletedNot Applicable

HIV Self-Testing AND Uptake and Retention of PrEP Among Older Adolescent MSM and TGW

Thailand600 participantsStarted 2018-10-15

Plain-language summary

This will be a prospective study that will enroll up to 600 older adolescent MSM and TGW from community-based clinics in Bangkok, Chonburi, Chiang Mai, and Songkhla.

Who can participate

Age range

15 Years – 19 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Thai nationality
. Age 15-19 years old
. Men or transgender women who have sex with men
. HIV-negative at the time of screening
. Have at least one of the following risks for HIV acquisition in the past 6 months:
. Any unprotected receptive anal sex with a male partner
. More than 5 male partners, regardless of condom use and serostatus
. Has had a bacterial sexually transmitted infection (STI)

Exclusion criteria

. HIV-positive
. Hepatitis B infection as indicated by positive hepatitis B surface antigen (HBsAg) test at time of screening
. Known allergy/sensitivity to tenofovir or emtricitabine

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Proportion of participants starting PrEP among those who use and do not use HIVST

Timeframe: 3 years

Proportion of participants taking PrEP retaining in care among those who use and do not use HIVST

Timeframe: 3 years

Trial details

NCT IDNCT03745495

SponsorThai Red Cross AIDS Research Centre

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-12-15

View on ClinicalTrials.gov More Men or Transgender Women Who Have Sex With Men trials